Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02905032 · ClinicalTrials.gov registry record · NA
SDM for Stroke Prevention in Atrial Fibrillation
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,186
- Enrollment target
NCT02905032: Completed NA study, sponsored by Mayo Clinic.
NCT02905032 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 1,186 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02905032, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,186 participants
- Enrollment target
Study Summary
The objective of this project is to evaluate a treatment decision aid for patients with atrial fibrillation.
Primary Outcome
The number of encounters that the clinicians were satisfied with the decision-making process. The results reported for this Outcome Measure reflect the response of the clinician for each patient. A 5 point likert scale questioning satisfaction with discussion about anticoagulation medication choice. The 5 point likert scale ranges from 1-5, with 1 being not at all satisfied and 5 being completely satisfied. Any values of 4 or 5 were considered to be satisfied.
Interventions
- BEHAVIORAL Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,186 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2020-06-27 |
| Phase | NA |
What the finished NCT02905032 record still lists
NCT02905032 is an interventional study that assigns participants to a tested intervention. Its 1,186 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (16% lower).
The record links to 0 conditions, and to 1 intervention - of which Decision Aid is the first listed.
NCT02905032 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02905032 about?
NCT02905032 is a clinical study titled "SDM for Stroke Prevention in Atrial Fibrillation". The objective of this project is to evaluate a treatment decision aid for patients with atrial fibrillation.
What is the current status of trial NCT02905032?
This trial is currently completed. It is a NA study. The enrollment target is 1,186 participants. The study started on 2016-09-01. Estimated completion is 2020-06-27.
What interventions are being tested in trial NCT02905032?
The interventions under investigation include: Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT02905032?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02905032's enrollment target sits among peer trials
1,186 89th of 2000 higher than 1,912 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04293562 · 1,186 participants · Phase 3
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
- NCT05580419 · 1,188 participants · NA
Impact of 4PCP on Practitioner and Patient Outcomes
- NCT06290869 · 1,188 participants · Phase 3
Tobacco Education and Lung Health Study (TEAL)
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI